Provided by Tiger Trade Technology Pte. Ltd.

ProShares Pet Care ETF

46.76
+0.32960.71%
Post-market: 46.880.1204+0.26%19:30 EDT
Volume:362
Turnover:16.96K
Market Cap:30.39M
PE:- -
High:46.88
Open:46.88
Low:46.76
Close:46.43
52wk High:57.44
52wk Low:45.96
Shares:650.00K
Float Shares:650.00K
Volume Ratio:0.18
T/O Rate:0.06%
Dividend:0.36
Dividend Rate:0.77%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

IDEXX Laboratories Adds Taeniid Tapeworm Detection to Parasite Testing Platform

MT Newswires Live
·
Sep 17

Revvity Inc. Stock Climbs 4.0%, Outperforms Peers

Dow Jones
·
Sep 17

Freshpet Director N. Walter George Acquires $64,920 of Common Shares

Reuters
·
Sep 17

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 16

IDEXX Laboratories Acquires Veterinary AI Workflow Software Provider CoVetAI

Reuters
·
Sep 16

IDEXX Laboratories, - Financial Terms of Covetai Acquisition not Disclosed

THOMSON REUTERS
·
Sep 16

IDEXX Laboratories Acquires Covetai to Advance Veterinary Workflow Intelligence

THOMSON REUTERS
·
Sep 16

Revvity Inc. Stock Climbs 9.1%, Outperforms Peers

Dow Jones
·
Sep 16

Pet Insurance or Savings Account: What's the Best Way to Plan for a Big Vet Bill?

Dow Jones
·
Sep 15

RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)

TIPRANKS
·
Sep 15

Merck & Co Exec Says Potential 340B and Policy Evolutions Would Create Tailwinds but are not Material to the Business - Morgan Stanley Conf

THOMSON REUTERS
·
Sep 15

Merck & Co Exec Says Timing for Raising the $70 Bln Forecast is "to be Determined" Adds "It's Coming"

THOMSON REUTERS
·
Sep 15

Chewy Shares Gain on Mixed Shelf Offering

Dow Jones
·
Sep 14

Pet Insurance Surges in Insurer Earnings Reports, Yet Market Penetration Hovers Below 4%

Deep News
·
Sep 14

Analysts Offer Insights on Consumer Cyclical Companies: Five Below (FIVE) and Chewy (CHWY)

TIPRANKS
·
Sep 14

Perspective Therapeutics Enters Cancer Clinical Trial Collaboration With Merck; Shares Up Pre-Bell

MT Newswires Live
·
Sep 14

Chewy Inc Files for Mixed Shelf; Size not Disclosed - SEC Filing

THOMSON REUTERS
·
Sep 14

Perspective Therapeutics Partners with Merck to Test [212Pb]PSV359 with Keytruda in FAP-Α-Positive Solid Tumors

Reuters
·
Sep 14

Perspective Therapeutics, - Co Sponsors Study; Merck Provides Pembrolizumab at no Cost

THOMSON REUTERS
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14